Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

688098.SS Gross Margin

The Gross Margin of Shanghai Shen Lian Biomedical Corp (688098.SS) is 70.85%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

688098.SS Gross Margin - Historical Value
Date Value
2023-12-31 70.85%
2022-12-31 75.23%
2021-12-31 75.72%
2020-12-31 83.68%
2019-12-31 82.27%
2018-12-31 80.15%
2017-12-31 79.94%
2016-12-31 78.18%
688098.SS Gross Margin - Peers Comparison
Ticker Name Value
605116.SS Aurisco Pharmaceutical Co Ltd 55.31%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 83.54%
688566.SS Jiangsu Jibeier Pharmaceutical Co Ltd 89.38%
688356.SS Jenkem Technology Co Ltd 79.00%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 58.25%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 76.81%
300871.SZ Wuhan Hvsen Biotechnology Co Ltd 20.66%
300878.SZ Zhejiang Wecome Pharmaceutical Co Ltd 50.28%
600851.SS Shanghai Haixin Group Co Ltd 46.37%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 73.17%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 74.19%
002118.SZ Jilin Zixin Pharmaceutical Industrial Co Ltd 58.50%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 54.82%
300636.SZ Jiangxi Synergy Pharmaceutical Co Ltd 30.65%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 76.91%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 68.27%
603222.SS Chimin Health Management Co Ltd 42.05%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 89.02%
002750.SZ Kunming Longjin Pharmaceutical Co Ltd 54.40%
002644.SZ Lanzhou Foci Pharmaceutical Co Ltd 30.97%
300199.SZ Hybio Pharmaceutical Co Ltd 40.71%
600381.SS Qinghai Spring Medicinal Resources Technology Co Ltd 60.18%
603079.SS Zhejiang Shengda Bio-Pharm Co Ltd 10.17%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd 55.87%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 63.30%
603566.SS Pulike Biological Engineering Inc 60.76%
603676.SS Tibet Weixinkang Medicine Co Ltd 50.76%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 79.78%